sonar-pro
Specifically mandates the use of a “red dot” symbol on prescription-only pharmaceutical products.
{
  "id": "748c2a7e-f4f7-4039-8081-124bd750e83e",
  "choices": [
    {
      "finish_reason": "stop",
      "index": 0,
      "logprobs": null,
      "message": {
        "content": "{\n  \"answer\": \"NO\",\n  \"note\": \"There is no mandate in Philippine pharmaceutical labeling regulations, such as Administrative Order No. 55 s. 1988, that requires the use of a 'red dot' symbol on prescription-only medicines[1]. The regulations specify detailed requirements for labeling, including prominence of the generic name, inclusion of product and manufacturer details, and specific elements for biologicals and injectables, but make no mention of a red dot symbol. While some ASEAN countries or regional organizations may use such symbols, no credible authoritative Philippine source confirms that this is a legal requirement in the Philippines[1][2][5].\"\n}",
        "refusal": null,
        "role": "assistant",
        "annotations": null,
        "audio": null,
        "function_call": null,
        "tool_calls": null
      },
      "delta": {
        "role": "assistant",
        "content": ""
      }
    }
  ],
  "created": 1755743882,
  "model": "sonar-pro",
  "object": "chat.completion",
  "service_tier": null,
  "system_fingerprint": null,
  "usage": {
    "completion_tokens": 134,
    "prompt_tokens": 21,
    "total_tokens": 155,
    "completion_tokens_details": null,
    "prompt_tokens_details": null,
    "search_context_size": "low",
    "cost": {
      "input_tokens_cost": 0.0,
      "output_tokens_cost": 0.002,
      "request_cost": 0.006,
      "total_cost": 0.008
    }
  },
  "citations": [
    "https://www.slideshare.net/slideshow/ra-55/45401812",
    "http://www.tsmia.or.th/RTD2022/Self-CARER_e-book_final.pdf",
    "https://www.fda.gov/food/hfp-constituent-updates/fda-revoke-authorization-use-red-no-3-food-and-ingested-drugs",
    "https://www.guttmacher.org/sites/default/files/report_pdf/abortion-methodologies.pdf",
    "https://www.raps.org/news-and-articles/news-articles/2018/1/the-drug-regulatory-landscape-in-the-asean-region"
  ],
  "search_results": [
    {
      "title": "Ra 55 | PDF | Pharmaceutical Drugs | Medical Health",
      "url": "https://www.slideshare.net/slideshow/ra-55/45401812",
      "date": "2015-03-03",
      "last_updated": "2025-05-01"
    },
    {
      "title": "Self-CARER",
      "url": "http://www.tsmia.or.th/RTD2022/Self-CARER_e-book_final.pdf",
      "date": "2015-09-17",
      "last_updated": null
    },
    {
      "title": "Revoking Authorization for the Use of Red No. 3 in Food ...",
      "url": "https://www.fda.gov/food/hfp-constituent-updates/fda-revoke-authorization-use-red-no-3-food-and-ingested-drugs",
      "date": "2025-01-15",
      "last_updated": "2025-06-16"
    },
    {
      "title": "Methodologies for Estimating Abortion Incidence and ...",
      "url": "https://www.guttmacher.org/sites/default/files/report_pdf/abortion-methodologies.pdf",
      "date": null,
      "last_updated": null
    },
    {
      "title": "The Drug Regulatory Landscape in the ASEAN Region",
      "url": "https://www.raps.org/news-and-articles/news-articles/2018/1/the-drug-regulatory-landscape-in-the-asean-region",
      "date": "2018-01-30",
      "last_updated": null
    }
  ]
}